Thumbnail Image
Publication

EGFR Exon 20 insertion (A763_Y764insFQEA) mutant NSCLC is not identified by Roche Cobas Version 2 tissue testing but has durable intracranial and extracranial response to osimertinib

Coleman, N.
; 
Woolf, David K
; 
Welsh, L.
; 
McDonald, F.
; 
MacMahon, S.
; 
Yousaf, N.
; 
Popat, S.
Citations
Altmetric:
Abstract
None
Authors
Coleman, N.
Woolf, David K
Welsh, L.
McDonald, F.
MacMahon, S.
Yousaf, N.
Popat, S.
Affiliation
Lung Unit, The Royal Marsden Hospital, Chelsea, London, United Kingdom; Institute of Cancer Research, Sutton, London,
Description
Date
2020
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Article
Citation
Coleman N, Woolf D, Welsh L, McDonald F, MacMahon S, Yousaf N, et al. EGFR Exon 20 Insertion (A763_Y764insFQEA) Mutant NSCLC Is Not Identified by Roche Cobas Version 2 Tissue Testing but Has Durable Intracranial and Extracranial Response to Osimertinib. J Thorac Oncol. 2020;15(10):e162-e5.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/623363
Embedded videos